8-K//Current report
ENDRA Life Sciences Inc. 8-K
Accession 0001213900-25-121374
$NDRACIK 0001681682operating
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 12, 8:31 PM ET
Size
219.2 KB
Accession
0001213900-25-121374
Documents
- 8-Kea0269386-8k_endra.htmPrimary
CURRENT REPORT
- EX-3.1ea026938601ex3-1_endra.htm
CERTIFICATE OF AMENDMENT TO THE COMPANY'S FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK, EFFECTIVE DECEMBER 10, 2025
- EX-101.SCHndra-20251209.xsd
XBRL SCHEMA FILE
- EX-101.LABndra-20251209_lab.xml
XBRL LABEL FILE
- EX-101.PREndra-20251209_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-121374-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0269386-8k_endra_htm.xml
IDEA: XBRL DOCUMENT
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001681682
Filing Metadata
- Form type
- 8-K
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 12, 8:31 PM ET
- Size
- 219.2 KB